StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$47.76−0.06 (-0.13%)

Close on Nov 20, 2026Market cap $103.05BP/E 13.0Yield –

GSK net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was £5.72B, up 122.0% from the year before. Over ten years it grew -3.8% a year on average. The highest annual figure on record is £14.96B in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025£5.72B+122.0%
FY2024Dec 31, 2024£2.58B-47.7%
FY2023Dec 31, 2023£4.93B-67.1%
FY2022Dec 31, 2022£14.96B+241.1%
FY2021Dec 31, 2021£4.39B-23.7%
FY2020Dec 31, 2020£5.75B+23.8%
FY2019Dec 31, 2019£4.65B+28.2%
FY2018Dec 31, 2018£3.62B+136.5%
FY2017Dec 31, 2017£1.53B+68.0%
FY2016Dec 31, 2016£912.00M-89.2%
FY2015Dec 31, 2015£8.42B–

More GSK figures

See a number that looks wrong?